Table 1 Characteristics of the study participants at discharge
Characteristics at discharge | HIV− (n = 722) | HIV+ (n = 112) | Total (N = 834) | |
---|---|---|---|---|
Demographic | ||||
Sex – Males N (%) | 410 (57%) | 63 (56%) | 473 (57%) | |
Age, months – Median (IQR) | 12.7 (8.0–17.5) | 12.1 (6.2–17.8) | 12.6 (7.9–17.5) | |
Site – N (%) | ||||
Banfora | 128 (18%) | 4 (3.6%) | 132 (16%) | |
Blantyre | 83 (11%) | 39 (35%) | 122 (15%) | |
Kampala | 210 (29%) | 27 (24%) | 237 (28%) | |
Kilifi | 88 (12%) | 13 (12%) | 101 (12%) | |
Migori | 131 (18%) | 22 (20%) | 153 (18%) | |
Nairobi | 82 (11%) | 7 (6.3%) | 89 (11%) | |
Nutritional status at discharge – N (%) | ||||
No wasting | 276 (38%) | 22 (20%) | 298 (36%) | |
Moderate wasting | 197 (27%) | 27 (24%) | 224 (27%) | |
Severe wasting | 249 (34%) | 63 (56%) | 312 (37%) | |
Anthropometry at discharge | ||||
MUAC (cm) | Median (IQR) Mean (SD) | 12.15 (11.15–13.20) 12.15 (±1.66) | 11.25 (9.95–12.28) 11.13 (±1.58) | 12.05 (10.95–13.10) 12.01 (±1.68) |
WAZ score | Median (IQR) Mean (SD) | −2.42 (−3.62 to −1.27) −2.47 (±1.76) | −3.58 (−4.76 to −2.37) −3.46 (±1.66) | −2.59 (−3.82 to −1.35) −2.60 (±1.78) |
WHZ score | Median (IQR) Mean (SD) | −1.82 (−2.88 to −0.68) −1.77 (±1.62) | −2.72 (−3.76 to −1.16) −2.52 (±2.01) | −1.90 (−3.00 to −0.77) −1.87 (±1.70) |
HAZ score | Median (IQR) Mean (SD) | −2.08 (−3.34 to −1.08) −2.17 (±1.85) | −2.88 (−4.16 to −1.85) −3.01 (±1.87) | −2.18 (−3.46 to −1.15) −2.28 (±1.87) |
Oedema N (%) | 20 (2.9%) | 3 (2.8%) | 23 (2.9%) | |
Clinical illness at admission – N (%) | ||||
Diarrhoea | 289 (40%) | 51 (46%) | 340 (41%) | |
Pneumonia | 358 (50%) | 52 (46%) | 410 (49%) | |
Malaria Positive (RDT) | 140 (20%) | 6 (5.6%) | 146 (18%) | |
Measles | 17 (2.4%) | 1 (0.9%) | 18 (2.2%) | |
Sepsis | 39 (5.4%) | 10 (9.3%) | 49 (5.9%) | |
Pulmonary TB | 15 (2.1%) | 12 (11%) | 27 (3.3%) | |
On Co-trimoxazole prophylaxis and Antiretroviral treatment at admission – N (%) | ||||
Co-trimoxazole prophylaxis | 9 (1.2%) | 31 (28%) | 40 (4.8%) | |
Antiretroviral treatment (ART) | – | 29 (26%) | – |